_    ___ ___      _                               
   / \  |_ _/ _ \ ___| |_ _ __ ___  __ _ _ __ ___  ___
  / _ \  | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
 / ___ \ | | |_| \__ \ |_| | |  __/ (_| | | | | | \__ \
/_/   \_\___\___/|___/\__|_|  \___|\__,_|_| |_| |_|___/

Invidious > Channel > EBD Group

EBD Group	1100 subscribers    RSS
View channel on YouTube Videos Playlists

YT 3 minutes 33 seconds EBD Group BIO-Europe® 2018: CEO of Alligator Bioscience on the company's BD strategies in immuno-oncology YT 5 minutes 25 seconds EBD Group BIO-Europe® 2018: RedHill BioPharma takes an antibiotic approach to Crohn's disease YT 6 minutes 27 seconds EBD Group BIO-Europe® 2018: Galecto Biotech's CMO discusses the company's recent EUR 79m Series C financing

YT 7 minutes 44 seconds EBD Group BIO-Europe® 2018: Lundbeck's new CEO discusses the company's road ahead in CNS research YT 4 minutes 1 second EBD Group BIO-Europe® 2018: ReVision Therapeutics on potential fast path for drugs treating rare eye diseases YT 8 minutes 49 seconds EBD Group BIO-Europe® 2018: BioNTech CBO outlines infectious disease ambitions

YT 5 minutes 50 seconds EBD Group BIO-Europe® 2018: SunRegen reveals transformative solution to neurodegenerative eye disease YT 9 minutes 10 seconds EBD Group BIO-Europe® 2018: Synairgen developing COPD treatment to hold off further viral damage YT 10 minutes 53 seconds EBD Group BIO-Europe® 2018: EU biotechs can create more value with US presence

YT 8 minutes 42 seconds EBD Group BIO-Europe® 2018: Novo Seeds describes company-building aspirations YT 8 minutes 11 seconds EBD Group BIO-Europe®: Molecule diversity creates developmental challenges for aspiring commercial biotechs YT 10 minutes 2 seconds EBD Group BIO-Europe® 2018: Pharma needs to focus on drug formulation earlier in development cycle

YT 12 minutes 36 seconds EBD Group BIO-Europe® 2018: Creating combinations to target glial cells and improve CNS drug efficacy YT 11 minutes 4 seconds EBD Group BIO-Europe 2018®: Targeting SK channels to tackle atrial fibrillation YT 9 minutes 24 seconds EBD Group BIO-Europe 2018®: Targeting ROS and redox perturbations to tackle mitochondrial diseases

YT 9 minutes 44 seconds EBD Group BIO-Europe 2018®: UTILITY positions established antibiotic to tackle US resistance YT 8 minutes 42 seconds EBD Group BIO-Europe 2018®: Boutique CROs best placed to help biotechs advance assets into clinic YT 10 minutes 47 seconds EBD Group BIO-Europe 2018®: Nanotechnology approach enables Cristal to focus tumor targeting

YT 7 minutes 15 seconds EBD Group BIO-Europe® 2018: Life Biosciences aims to solve for aging